全球数位 PCR 市场规模、份额、成长分析，按技术（液滴数位 PCR 和基于晶片的数位 PCR）、产品类型、应用 - 产业预测 2024-2031

2022 年全球数位 PCR 市场规模预计为 59.5 亿美元，预计将从 2023 年的 64.9 亿美元成长到 2031 年的 130.7 亿美元，预测期内（2024-2031 年）复合年增长率为 9.14%。

由于对精确核酸定量和分析的需求不断增长，全球数位 PCR（聚合酶炼式反应）市场正在经历快速成长。数位 PCR 以其无与伦比的准确性和灵敏度而闻名，是基因检测、疾病诊断和研究工作的重要工具，旨在提供先进的分子诊断解决方案。主要驱动因素包括遗传性疾病和传染病的盛行率不断上升，以及对个人化医疗和基因组研究进展的需求激增。儘管如此，数位 PCR 仪器的高成本和最终用户意识有限等挑战阻碍了市场的发展。值得注意的趋势包括数位 PCR 与下一代定序技术的整合以及用于同时检测各种目标的多重数位 PCR 检测的开发。儘管存在障碍，但新兴经济体采用率的提高、肿瘤学和传染病诊断应用的扩大以及功能增强的创新产品的推出，仍带来了巨大的扩展机会。

目录

执行摘要

• 市场概况
• 命运之轮

研究方法论

• 资讯采购
• 二手和主要资料来源
• 市场规模估计
• 市场假设与限制

母公司市场分析

• 市场概况
• 市场规模
• 市场动态
  • 司机
  • 机会
  • 限制
  • 挑战

主要市场洞察

• 技术分析
• 定价分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 智慧财产权分析
• 贸易分析
• 启动分析
• 原料分析
• 创新矩阵
• 管道产品分析
• 总体经济指标
• 顶级投资分析
• 成功的关键因素
• 竞争程度

市场动态与展望

• 市场动态
  • 司机
  • 机会
  • 限制
  • 挑战
• 监管环境
• 波特分析
• 对未来颠覆的特别见解

按技术分類的全球数位 PCR 市场

• 市场概况
• 液滴数位 PCR (ddPCR) 和晶片数位 PCR (cdPCR)

按产品类型分類的全球数位 PCR 市场

• 市场概况
• 仪器
• 试剂及耗材
• 软体和服务

按应用分類的全球数位 PCR 市场

• 市场概况
• 临床诊断
• 研究
• 法医
• 和环境监测影像

全球数位 PCR 市场规模（按地区）

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 拉丁美洲其他地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • MEA 的其余部分

竞争格局

• 前 5 名玩家比较
• 2021 年关键参与者的市场定位
• 主要市场参与者所采取的策略
• 最佳制胜策略
• 近期市集活动
• 主要公司市占率（%），2021年

主要公司简介

• Thermo Fisher Scientific (US)
• Bio-Rad Laboratories (US)
• QIAGEN (Germany)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Fluidigm Corporation (US)
• Merck KGaA (Germany)
• Agilent Technologies (US)
• BioMA(C)rieux SA (France)
• Takara Bio Inc. (Japan)
• Danaher Corporation (US)
• JN Medsys (Singapore)
• RainDance Technologies (US)
• Formulatrix, Inc. (US)
• Stilla Technologies (France)
• Becton, Dickinson and Company (US)
• Analytik Jena AG (Germany)
• Douglas Scientific (US)
• Sysmex Corporation (Japan)
• GenMark Diagnostics, Inc. (US)
• Quantabio (US)

Global Digital PCR Market size was valued at USD 5.95 Billion in 2022 and is poised to grow from USD 6.49 Billion in 2023 to USD 13.07 Billion by 2031, at a CAGR of 9.14% during the forecast period (2024-2031).

The Global Digital PCR (Polymerase Chain Reaction) Market is experiencing rapid growth due to rising demand for precise nucleic acid quantification and analysis. Digital PCR, known for its unmatched accuracy and sensitivity, serves as a vital tool in genetic testing, disease diagnosis, and research endeavors, aiming to provide advanced molecular diagnostic solutions. Key drivers include the escalating prevalence of genetic disorders and infectious diseases, alongside a surge in demand for personalized medicine and genomic research advancements. Nonetheless, challenges such as the high cost of digital PCR instruments and limited end-user awareness hinder market progression. Noteworthy trends involve the integration of digital PCR with next-generation sequencing technologies and the development of multiplex digital PCR assays for simultaneous detection of various targets. Despite obstacles, significant expansion opportunities arise from increased adoption in emerging economies, widening applications in oncology and infectious disease diagnostics, and the introduction of innovative products with enhanced features.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital PCR Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital PCR Market Segmental Analysis

Global Digital PCR Market is segmented on the basis of technology, product type, application, and region. By technology, the market is segmented into droplet digital PCR (ddPCR) and chip-based digital PCR (cdPCR). By product type, the market is segmented into instruments, reagents and consumables, and software and services. By application, the market is segmented into clinical diagnostics, research, forensics, and environmental monitoring. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Digital PCR Market

The significant growth of the market for digital polymerase chain reaction (dPCR) is being propelled by remarkable technological advancements. This evolution from traditional PCR techniques enables direct quantification and clonal amplification of nucleic acids, meeting the rising demand for more precise and efficient diagnostic tools. With a surge in research and development efforts, diverse PCR technologies are emerging, presenting substantial advantages and driving further innovation in the field.

Restraints in the Global Digital PCR Market

The widespread uptake of digital PCR technology might encounter obstacles due to the substantial initial expenses linked with acquiring instruments and reagents. Digital PCR platforms demand specialized equipment and consumables, which could pose a financial challenge for research labs or smaller healthcare institutions. Such high expenditures might restrict the availability of digital PCR technology, especially in resource-constrained environments or for researchers facing budgetary limitations.

Market Trends of the Global Digital PCR Market

The integration of digital PCR and NGS technologies offers a comprehensive approach to genomic analysis, as they complement each other effectively. By combining digital PCR's precise quantification with NGS's sequencing capabilities, researchers can acquire both qualitative and quantitative genomic insights. This integrated approach enables the detection of rare genetic variants, validation of NGS findings, and thorough analysis of intricate genomic changes associated with various diseases.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Digital PCR Market by Technology

• Market Overview
• droplet digital PCR (ddPCR) and chip-based digital PCR (cdPCR)

Global Digital PCR Market by Product Type

• Market Overview
• instruments
• reagents and consumables
• and software and services

Global Digital PCR Market by Application

• Market Overview
• clinical diagnostics
• research
• forensics
• and environmental monitoring Image

Global Digital PCR Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMA(C)rieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JN Medsys (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RainDance Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Formulatrix, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stilla Technologies (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Analytik Jena AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Douglas Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quantabio (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments